Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Clinical trial NCT03566823 · TERMINATED
Trial details
- NCT number
- NCT03566823
- Sponsor
- Shire
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2020-08-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.